Top

Internal and Emergency Medicine

Published in:

01-11-2020 | COVID-19 | CE - LETTER TO THE EDITOR

Systematic review of the prevalence of current smoking among hospitalized COVID‑19 patients in China: could nicotine be a therapeutic option?

Author: Hisato Takagi

Published in: Internal and Emergency Medicine | Issue 8/2020

Excerpt

Dear Editor, …

Available only for authorised users

Farsalinos K, Barbouni A, Niaura R (2020) Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med. https://doi.org/10.1007/s11739-020-02355-7CrossRefPubMedPubMedCentral

Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, Ye C, Zhang P, Xing Y, Guo H, Tang W (2020) Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. https://doi.org/10.1016/j.jinf.2020.04.021CrossRefPubMedPubMedCentral

Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N, Deng Y, Lin S (2020) The impact of COPD and smoking history on the severity of Covid-19: a systemic review and meta-analysis. J Med Virol. https://doi.org/10.1002/jmv.25889CrossRefPubMedPubMedCentral

Oakes JM, Fuchs RM, Gardner JD, Lazartigues E, Yue X (2018) Nicotine and the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 315:R895–R906CrossRefPubMedCentralPubMed

Polosa R, Caci G (2020) COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine. Intern Emerg Med. https://doi.org/10.1007/s11739-020-02361-9CrossRefPubMedPubMedCentral

Title: Systematic review of the prevalence of current smoking among hospitalized COVID‑19 patients in China: could nicotine be a therapeutic option?
Author: Hisato Takagi
Publication date: 01-11-2020
Publisher: Springer International Publishing
Keyword: COVID-19
Published in: Internal and Emergency Medicine / Issue 8/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-020-02473-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2020

Early predictors of in-hospital mortality in patients with COVID-19 in a large American cohort

Telemedicine in the acute care setting during the COVID-19 pandemic

Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy

Liver transplantation in Italy in the era of COVID 19: reorganizing critical care of recipients

A woman with fever and cough: coronavirus disease 2019

The COVID-19 epidemic and reorganisation of triage, an observational study

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials